SCOPUS 정보 검색 플랫폼

OncoImmunology

Volumn 3, Issue 12, 2014, Pages 1-3

Reversal of natural killer cell exhaustion by TIM-3 blockade

(4) Gallois, Anne a Silva, Ines b Osman, Iman b Bhardwaj, Nina a

a MOUNT SINAI SCHOOL OF MEDICINE (United States)

b NEW YORK UNIVERSITY MEDICAL CENTER (United States)

Author keywords

exhaustion; immune checkpoint; melanoma; natural killer cells; Tim 3

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ECALECTIN; EOMESODERMIN; GAMMA INTERFERON; INTERLEUKIN 15; INTERLEUKIN 2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; MEMBRANE PROTEIN; NATURAL KILLER CELL RECEPTOR NKG2D; PROGRAMMED DEATH 1 RECEPTOR; T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN CONTAINING MOLECULE 3; UNCLASSIFIED DRUG;

ARTICLE; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; GENE OVEREXPRESSION; HUMAN; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; METASTATIC MELANOMA; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; OVERALL SURVIVAL; PROTEIN EXPRESSION;

EID: 84938799943 PISSN: 21624011 EISSN: 2162402X Source Type: Journal
DOI: 10.4161/21624011.2014.946365 Document Type: Article

Times cited : (80)

References (10)

1
- 77954801079
- Improved survival with ipilimumab in patients with metastatic melanoma
- 20525992
- F.S.Hodi, S.J.O'Day, D.F.McDermott, R.W.Weber, J.A.Sosman, J.B.Haanen, R.Gonzalez, C.Robert, D.Schadendorf, J.C.Hassel, Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363:711-23; PMID:20525992; http://dx.doi.org/10.1056/NEJMoa1003466
- (2010) N Engl J Med , vol.363 , pp. 711-723
- Hodi, F.S.¹ O'Day, S.J.² McDermott, D.F.³ Weber, R.W.⁴ Sosman, J.A.⁵ Haanen, J.B.⁶ Gonzalez, R.⁷ Robert, C.⁸ Schadendorf, D.⁹ Hassel, J.C.¹⁰

2
- 84862859820
- Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
- 22658127
- S.L.Topalian, F.S.Hodi, J.R.Brahmer, S.N.Gettinger, D.C.Smith, D.F.McDermott, J.D.Powderly, R.D.Carvajal, J.A.Sosman, M.B.Atkins, Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med 2012; 366:2443-54; PMID:22658127; http://dx.doi.org/10.1056/NEJMoa1200690
- (2012) N. Engl. J. Med , vol.366 , pp. 2443-2454
- Topalian, S.L.¹ Hodi, F.S.² Brahmer, J.R.³ Gettinger, S.N.⁴ Smith, D.C.⁵ McDermott, D.F.⁶ Powderly, J.D.⁷ Carvajal, R.D.⁸ Sosman, J.A.⁹ Atkins, M.B.¹⁰

3
- 77957723967
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
- 20819923
- J.Fourcade, Z.Sun, M.Benallaoua, P.Guillaume, I.F.Luescher, C.Sander, J.M.Kirkwood, V.Kuchroo, H.M.Zarour. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients. J Exp Med 2010; 207:2175-86; PMID:20819923; http://dx.doi.org/10.1084/jem.20100637
- (2010) J Exp Med , vol.207 , pp. 2175-2186
- Fourcade, J.¹ Sun, Z.² Benallaoua, M.³ Guillaume, P.⁴ Luescher, I.F.⁵ Sander, C.⁶ Kirkwood, J.M.⁷ Kuchroo, V.⁸ Zarour, H.M.⁹

4
- 77957744369
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- 20819927
- K.Sakuishi, L.Apetoh, J.M.Sullivan, B.R.Blazar, V.K.Kuchroo, A.C.Anderson. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med 2010; 207:2187-94; PMID:20819927; http://dx.doi.org/10.1084/jem.20100643
- (2010) J Exp Med , vol.207 , pp. 2187-2194
- Sakuishi, K.¹ Apetoh, L.² Sullivan, J.M.³ Blazar, B.R.⁴ Kuchroo, V.K.⁵ Anderson, A.C.⁶

5
- 84862493242
- Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells
- 22544698
- S.Gill, A.E.Vasey, A.De Souza, J.Baker, A.T.Smith, H.E.Kohrt, M.Florek, K.D.GibbsJr, K.Tate, D.S.Ritchie, Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells. Blood 2012; 119:5758-68; PMID:22544698; http://dx.doi.org/10.1182/blood-2012-03-415364
- (2012) Blood , vol.119 , pp. 5758-5768
- Gill, S.¹ Vasey, A.E.² De Souza, A.³ Baker, J.⁴ Smith, A.T.⁵ Kohrt, H.E.⁶ Florek, M.⁷ Gibbs, K.D.⁸ Tate, K.⁹ Ritchie, D.S.¹⁰

6
- 80052346280
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- 21841316
- E.Mamessier, A.Sylvain, M.L.Thibult, G.Houvenaeghel, J.Jacquemier, R.Castellano, A.Gonlves, P.Andr, F.Romagn, G.Thibault, Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. J Clin Invest 2011; 121:3609-22; PMID:21841316; http://dx.doi.org/10.1172/JCI45816
- (2011) J Clin Invest , vol.121 , pp. 3609-3622
- Mamessier, E.¹ Sylvain, A.² Thibult, M.L.³ Houvenaeghel, G.⁴ Jacquemier, J.⁵ Castellano, R.⁶ Gonlves, A.⁷ Andr, P.⁸ Romagn, F.⁹ Thibault, G.¹⁰

7
- 80051675837
- Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma
- 21708957
- S.Platonova, J.Cherfils-Vicini, D.Damotte, L.Crozet, V.Vieillard, P.Validire, P.Andr, M.C.Dieu-Nosjean, M.Alifano, J.F.Rnard, Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma. Cancer Res 2011; 71:5412-22; PMID:21708957; http://dx.doi.org/10.1158/0008-5472.CAN-10-4179
- (2011) Cancer Res , vol.71 , pp. 5412-5422
- Platonova, S.¹ Cherfils-Vicini, J.² Damotte, D.³ Crozet, L.⁴ Vieillard, V.⁵ Validire, P.⁶ Andr, P.⁷ Dieu-Nosjean, M.C.⁸ Alifano, M.⁹ Rnard, J.F.¹⁰

8
- 84908397938
- Reversal of NK-cell exhaustion in advanced melanoma by tim-3 blockade
- 24795354
- I.P.da Silva, A.Gallois, S.Jimenez-Baranda, S.Khan, A.C.Anderson, V.K.Kuchroo, I.Osman, N.Bhardwaj, Reversal of NK-cell exhaustion in advanced melanoma by tim-3 blockade. Cancer Immunol Res 2014; 2:410-22; PMID:24795354; http://dx.doi.org/10.1158/2326-6066.CIR-13-0171
- (2014) Cancer Immunol Res , vol.2 , pp. 410-422
- da Silva, I.P.¹ Gallois, A.² Jimenez-Baranda, S.³ Khan, S.⁴ Anderson, A.C.⁵ Kuchroo, V.K.⁶ Osman, I.⁷ Bhardwaj, N.⁸

9
- 84859192882
- Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9
- 22323453
- M.K.Gleason, T.R.Lenvik, V.McCullar, M.Felices, M.S.O'Brien, S.A.Cooley, M.R.Verneris, F.Cichocki, C.J.Holman, A.Panoskaltsis-Mortari, Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9. Blood 2012; 119:3064-72; PMID:22323453; http://dx.doi.org/10.1182/blood-2011-06-360321
- (2012) Blood , vol.119 , pp. 3064-3072
- Gleason, M.K.¹ Lenvik, T.R.² McCullar, V.³ Felices, M.⁴ O'Brien, M.S.⁵ Cooley, S.A.⁶ Verneris, M.R.⁷ Cichocki, F.⁸ Holman, C.J.⁹ Panoskaltsis-Mortari, A.¹⁰

10
- 84860337409
- Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity
- 22383801
- L.C.Ndhlovu, S.Lopez-Verg, J.D.Barbour, R.B.Jones, A.R.Jha, B.R.Long, E.C.Schoeffler, T.Fujita, D.F.Nixon, L.L.Lanier. Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood 2012; 119:3734-43; PMID:22383801; http://dx.doi.org/10.1182/blood-2011-11-392951
- (2012) Blood , vol.119 , pp. 3734-3743
- Ndhlovu, L.C.¹ Lopez-Verg, S.² Barbour, J.D.³ Jones, R.B.⁴ Jha, A.R.⁵ Long, B.R.⁶ Schoeffler, E.C.⁷ Fujita, T.⁸ Nixon, D.F.⁹ Lanier, L.L.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.